Soltis Investment Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$297K Hold
140,750
0.02% 324
2025
Q1
$172K Hold
140,750
0.02% 354
2024
Q4
$182K Hold
140,750
0.02% 357
2024
Q3
$387K Buy
+140,750
New +$387K 0.04% 250